Trump administration withdraws 340B mega-guidance: 6 things to know

(By Ayla Ellison for Becker’s Hospital Review)

The Trump administration has withdrawn guidance on the 340B Drug Pricing Program that was under review at the end of the Obama administration. Continue reading article here…

Notice: The link provided above connects readers to the full content of the posted article. The URL (internet address) for this link is valid on the posted date; medicarereport.org cannot guarantee the duration of the link’s validity. Also, the opinions expressed in these postings are the viewpoints of the original source and are not explicitly endorsed by AMAC, Inc.; the AMAC Foundation, Inc.; or medicarereport.org.